T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNH
1226
CNH Industrial
CNH
$16.7B
| $4.92M | ﹤0.01% |
485,671
-6,862
| -1% | -$77.7K |
|
1227
Hawkins
HWKN
$2.67B
| $4.88M | ﹤0.01% |
53,601
+616
| +1% | +$50.5K |
|
1228
MasTec
MTZ
$23B
| $4.87M | ﹤0.01% |
45,467
+1,949
| +4% | +$197K |
|
1229
EnerSys
ENS
$7.2B
| $4.78M | ﹤0.01% |
46,155
+1,122
| +2% | +$110K |
|
1230
Darling Ingredients
DAR
$10.4B
| $4.77M | ﹤0.01% |
129,754
-30,271
| -19% | -$1.26M |
|
1231
PVH
PVH
$3.77B
| $4.75M | ﹤0.01% |
44,851
+880
| +2% | +$99.6K |
|
1232
Ryder
R
$10.1B
| $4.75M | ﹤0.01% |
38,322
+806
| +2% | +$97.3K |
|
1233
HealthEquity
HQY
$8.83B
| $4.72M | ﹤0.01% |
54,704
+3,320
| +6% | +$268K |
|
1234
Carlyle Group
CG
$18.3B
| $4.69M | ﹤0.01% |
116,735
+9,222
| +9% | +$398K |
|
1235
GameStop
GME
$8.33B
| $4.66M | ﹤0.01% |
188,821
+8,178
| +5% | +$162K |
|
1236
Omega Healthcare
OHI
$13.9B
| $4.66M | ﹤0.01% |
136,050
+2,884
| +2% | +$90.8K |
|
1237
Quaker Houghton
KWR
$2.95B
| $4.66M | ﹤0.01% |
27,445
-80,677
| -75% | -$14.9M |
|
1238
Minerals Technologies
MTX
$2.26B
| $4.58M | ﹤0.01% |
55,004
+2,275
| +4% | +$180K |
|
1239
LCI Industries
LCII
$2.6B
| $4.57M | ﹤0.01% |
44,191
-50,037
| -53% | -$5.4M |
|
1240
Barings BDC
BBDC
$987M
| $4.54M | ﹤0.01% |
465,995
-125,600
| -21% | -$1.2M |
|
1241
Diageo
DEO
$52.8B
| $4.53M | ﹤0.01% |
35,941
-37,929
| -51% | -$5.23M |
|
1242
Orchestra BioMed
OBIO
$267M
| $4.51M | ﹤0.01% |
552,703
-18,372
| -3% | -$106K |
|
1243
Roku
ROKU
$22.9B
| $4.49M | ﹤0.01% |
74,956
+3,782
| +5% | +$222K |
|
|
X
1244
DELISTED
US Steel
X
| $4.47M | ﹤0.01% |
118,234
+2,431
| +2% | +$92.8K |
|
1245
iShares MSCI Emerging Markets ETF
EEM
$30.5B
| $4.46M | ﹤0.01% |
104,802
| – | – |
|
1246
Knight Transportation
KNX
$11.9B
| $4.45M | ﹤0.01% |
89,098
+3,857
| +5% | +$189K |
|
1247
HF Sinclair
DINO
$16.3B
| $4.42M | ﹤0.01% |
82,956
+841
| +1% | +$47.3K |
|
1248
First American
FAF
$7.56B
| $4.42M | ﹤0.01% |
81,957
-162,345
| -66% | -$9.02M |
|
1249
SiTime
SITM
$20.7B
| $4.42M | ﹤0.01% |
35,502
+25,045
| +240% | +$2.67M |
|
1250
Gentex
GNTX
$4.99B
| $4.41M | ﹤0.01% |
130,826
+6,427
| +5% | +$222K |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.